Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

13.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.7K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

828
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
828
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanochemical Electron Donor-Acceptor (EDA)-Complex-Mediated Thioetherification Reaction via Site-Selective C-H Functionalization Using Aryl (DMIX)iodonium Salt.

The Journal of organic chemistry·2026
Same author

Mental health outcomes of living related donors for recipients with alcohol-associated hepatitis.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology·2026
Same author

Decarboxylative alkylation of unactivated olefins <i>via</i> photoinduced Fe-LMCT: access to alkylated dihydropyrazoles/tetrahydropyridazines.

Chemical communications (Cambridge, England)·2026
Same author

Naturalistic driving data can identify elevated driving risk in adults with Type 1 diabetes.

Traffic injury prevention·2026
Same author

Improving crash data quality by identifying misclassified alcohol-involved crashes using NLP on narrative data.

Journal of safety research·2026
Same author

Gene expression and metabolic regulation of carotenoid and withanolide biosynthetic pathways in Withania somnifera with emphasis on FPPS-mediated regulation.

Protoplasma·2026

Related Experiment Video

Updated: Jan 5, 2026

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo
10:39

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo

Published on: March 8, 2018

8.6K

Quantifying vehicle control from physiology in type 1 diabetes.

Pranamesh Chakraborty1, Jennifer Merickel2, Viraj Shah3

  • 1Department of Civil, Construction, and Environmental Engineering, Iowa State University, Ames, Iowa.

Traffic Injury Prevention
|October 17, 2019
PubMed
Summary

Type 1 diabetes drivers show impaired vehicle control linked to blood glucose levels, especially hypoglycemia. Monitoring driver physiology can help detect risks and improve safety for drivers with diabetes.

Keywords:
Diabetes mellitusdriving riskhypoglycemiavehicle control

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.9K
Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
07:41

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Published on: October 23, 2020

6.6K

Related Experiment Videos

Last Updated: Jan 5, 2026

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo
10:39

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo

Published on: March 8, 2018

8.6K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.9K
Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
07:41

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Published on: October 23, 2020

6.6K

Area of Science:

  • Diabetic Medicine
  • Transportation Safety
  • Human Factors Engineering

Background:

  • Type 1 diabetes (T1D) is associated with an elevated risk of motor vehicle crashes, primarily due to fluctuations in blood glucose levels.
  • Hypoglycemia, or low blood glucose, is a significant concern for T1D drivers, potentially impairing cognitive and motor functions necessary for safe driving.
  • Real-time monitoring of driver behavior and physiology offers a promising approach to understanding and mitigating these risks.

Purpose of the Study:

  • To quantify the real-world impact of at-risk driver physiology, specifically abnormal blood glucose in T1D individuals, on safety-critical driving tasks.
  • To test the hypotheses that T1D drivers exhibit impaired vehicle control, that these impairments correlate with physiological data, and that recent hypoglycemia exacerbates driving deficits.
  • To establish links between in-vehicle physiological data and objective measures of driving performance.

Main Methods:

  • Continuous, real-world monitoring of 18 T1D drivers and 14 control drivers over 4 weeks using in-vehicle sensors and continuous glucose monitors (CGMs).
  • Measurement of vehicle control via acceleration variability (AV) in lateral and longitudinal axes, analyzed in 45-second segments.
  • Statistical modeling using mixed-effects linear regression, controlling for average vehicle speed, to analyze the relationship between physiological data and AV.

Main Results:

  • T1D drivers demonstrated significantly higher overall acceleration variability (AV) compared to control drivers, indicating erratic steering and braking/accelerating.
  • At-risk vehicle control patterns, characterized by higher AV, were strongly associated with physiological states of hypo- and hyperglycemia.
  • Driving impairments linked to hypoglycemia persisted for hours post-resolution, with drivers experiencing hypoglycemia within 2-3 hours of driving showing significantly higher AV.

Conclusions:

  • Real-time monitoring reveals a direct link between the physiological state of T1D drivers, particularly hypoglycemia, and impaired vehicle control.
  • Objective measures of driving performance can detect hypoglycemia-related risks, informing fitness-to-drive assessments.
  • This research supports the development of proactive safety interventions for at-risk drivers with diabetes.